Market Data in North America

Published within

« | ... | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ... | » »|

Type Product title / description Pub Price
Interactive Model
Interactive Model

What Consumers Want 2012: Lending

An interactive tool providing direct answers to the questions which are central to developing a customer-centric strategy, the What Consumers Want series is an essential source of consumer insight at a country- and product-specific level.

Published By Datamonitor
20 Nov 2012 $5000
Buy
Interactive Model
Interactive Model

What Consumers Want 2012: Current Accounts

An interactive tool providing direct answers to the questions which are central to developing a customer-centric strategy, the What Consumers Want series is an essential source of consumer insight at a country- and product-specific level.

Published By Datamonitor
20 Nov 2012 $5000
Buy
Interactive Model
Interactive Model

Market Forecasts: Non-Small Cell Lung Cancer

There are 700,000 new cases of lung cancer each year and NSCLC constitutes about 80% of the total lung cancer patient population. Pharma have been attracted by the high incidence of this disease and the NSCLC pipeline has grown substantially.

Published By Datamonitor
19 Dec 2012 $6400
Buy
Interactive Model
Interactive Model

The Osteoporosis Market Forecast to 2021

New anti-bone loss drugs soon to reach the osteoporosis market - but generic entry will continue to erode its value.

Published By Datamonitor
17 Jan 2013 $6400
Buy
Interactive Model
Interactive Model

The Prostate Cancer Market Forecast to 2021

Recent approvals reinvigorate mCRPC market

Published By Datamonitor
18 Jan 2013 $6400
Buy
Interactive Model
Interactive Model

The Dyslipidemia Market Forecast to 2021

In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.

Published By Datamonitor
04 Feb 2013 $6400
Buy
Interactive Model
Interactive Model

The Vaccines Market Forecast to 2021

Strong growth expected in the vaccines market, as Sanofi Pasteur and Merck continue to dominate over the next 10 years.

Published By Datamonitor
13 Feb 2013 $6400
Buy
Interactive Model
Interactive Model

The Inflammatory Bowel Disease Market Forecast to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
22 Mar 2013 $6400
Buy
Interactive Model
Interactive Model

The Hepatitis C Market Forecast to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
17 Apr 2013 $6400
Buy
Interactive Model
Interactive Model

The Depression Market Forecast to 2021

The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.

Published By Datamonitor
25 Apr 2013 $6400
Buy

« | ... | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ... | » »|

No help is available.